{
  "id": 14140761,
  "title": "Samsung Biologics Secures 87.8% Stake in Polypeptide",
  "url": "https://urgent.news/2026/10/13/samsung-biologics-secures-87-8-stake-in-polypeptide",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-13T07:14:06.000Z",
  "source": {
    "name": "BusinessKorea",
    "slug": "businesskorea",
    "url": "https://www.businesskorea.co.kr/news/articleView.html?idxno=278695"
  },
  "original_language": "en",
  "account": null,
  "summary": "Samsung Biologics has passed a decisive hurdle to acquire Polypeptide Group, a global peptide contract development and manufacturing organization (CDMO). As the preliminary results of the tender offer showed that the tendered stake significantly exceeded the minimum acceptance condition, the company",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}